Christopher Gibson - 11 Mar 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
11 Mar 2022
Transactions value $
-$2,176,801
Form type
4
Filing time
15 Mar 2022, 20:57:24 UTC
Previous filing
09 Mar 2022
Next filing
07 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +100K +42.73% $0.00 334K 11 Mar 2022 Direct F1, F2
transaction RXRX Class A Common Stock Sale -$695K -100K -29.94% $6.95 234K 11 Mar 2022 Direct F3, F4
transaction RXRX Class A Common Stock Conversion of derivative security $0 +230K +98.28% $0.00 464K 14 Mar 2022 Direct F1, F2
transaction RXRX Class A Common Stock Sale -$1.44M -230K -49.57% $6.28 234K 14 Mar 2022 Direct F3, F5
transaction RXRX Class A Common Stock Conversion of derivative security $0 +6.15K +2.63% $0.00 240K 15 Mar 2022 Direct F1, F2
transaction RXRX Class A Common Stock Sale -$37.4K -6.15K -2.56% $6.08 234K 15 Mar 2022 Direct F3, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -100K -1.36% $0.00 7.26M 11 Mar 2022 Class A Common Stock 7.26M $0.00 Direct F1, F2
transaction RXRX Class B Common Stock Conversion of derivative security $0 -230K -3.17% $0.00 7.03M 14 Mar 2022 Class A Common Stock 7.03M $0.00 Direct F1, F2
transaction RXRX Class B Common Stock Conversion of derivative security $0 -6.15K -0.09% $0.00 7.02M 15 Mar 2022 Class A Common Stock 7.02M $0.00 Direct F1, F2
holding RXRX Stock Option (Right to Buy) 416K 11 Mar 2022 Class A Common Stock 416K $11.40 Direct F7
holding RXRX Stock Option (Right to Buy) 5.44K 11 Mar 2022 Class A Common Stock 5.44K $11.40 Direct
holding RXRX Stock Option (Right to Buy) 1.47M 11 Mar 2022 Class A Common Stock 1.47M $2.47 Direct F8
holding RXRX Class B Common Stock 550K 11 Mar 2022 Class A Common Stock 550K $0.00 by LAHWRAN-3 LLC F2, F9
holding RXRX Class B Common Stock 550K 11 Mar 2022 Class A Common Stock 550K $0.00 by LAHWRAN-4 LLC F2, F10
holding RXRX Class B Common Stock 147K 11 Mar 2022 Class A Common Stock 147K $0.00 by Gibson Family Trust F2, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion of Class B Common Stock into Class A Common Stock.
F2 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F3 Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral. As of March 15, 2022, Reporting Person has fully repaid the loan and no shares of the Company are currently serving as collateral for such loan.
F4 This transaction was executed in multiple trades at prices ranging from $6.72 to $7.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $6.065 to $6.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price
F6 This transaction was executed in multiple trades at prices ranging from $5.83 to $6.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price
F7 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F8 The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F9 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F11 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.